Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy
PositiveArtificial Intelligence
- A recent study evaluated the association between pretreatment MRI descriptors and the pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy. The retrospective analysis included 129 patients treated between 2016 and 2020, revealing that 46% achieved pCR, with significant differences noted across breast cancer subtypes.
- This development is crucial as it enhances the predictive capabilities of MRI in assessing treatment responses, potentially guiding more personalized therapeutic strategies for breast cancer patients.
- The findings contribute to a growing body of research focused on improving breast cancer diagnostics and treatment outcomes through advanced imaging techniques, machine learning applications, and the integration of various data sources, reflecting a broader trend towards precision medicine in oncology.
— via World Pulse Now AI Editorial System
